A prior investigation demonstrated that the diagnostic sensitivity of SHOX2 and RASSF1A combined methylation in lung adenocarcinoma was 52.5%, whereas cytology exhibited a sensitivity of 13.3%. This evidence concerns the gene RASSF1 and lung adenocarcinoma.